Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
Clinical trial NCT06136585 · RECRUITING
Trial details
- NCT number
- NCT06136585
- Sponsor
- The Cleveland Clinic
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-10-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.